Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes
- PMID: 16190224
- DOI: 10.1021/es0484799
Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes
Abstract
The potential occurrence of endocrine-disrupting compounds (EDCs) as well as pharmaceuticals and personal care products (PPCPs) in drinking water supplies raises concern over the removal of these compounds by common drinking water treatment processes. Three drinking water supplies were spiked with 10 to 250 ng/L of 62 different EDC/ PPCPs; one model water containing an NOM isolate was spiked with 49 different EDC/PPCPs. Compounds were detected by LC/MS/MS or GC/MS/MS. These test waters were subjected to bench-scale experimentation to simulate individual treatment processes in a water treatment plant (WTP). Aluminum sulfate and ferric chloride coagulants or chemical lime softening removed some polyaromatic hydrocarbons (PAHs) but removed <25% of most other EDC/ PPCPs. Addition of 5 mg/L of powder activated carbon (PAC) with a 4-h contact time removed 50% to >98% of GC/ MS/MS compounds (more volatile) and 10% to >95% of LC/ MS/MS compounds (more polar); higher PAC dosages improved EDC/PPCP removal. EDC/PPCP percentage removal was independent of the initial compound concentration. Octanol-water partition coefficients served as a reasonable indicator of compound removal under controlled PAC test conditions, except for EDC/PPCPs that were protonated or deprotonated at the test pH and some that contained heterocyclic or aromatic nitrogen. Separate chlorine or ozone experiments decreased the EDC/PPCP initial concentration by <10% to >90%; EDC/PPCPs were likely transformed to oxidation byproducts. Ozone oxidized steroids containing phenolic moieties (estradiol, ethynylestradiol, or estrone) more efficiently than those without aromatic or phenolic moieties (androstenedione, progesterone, and testosterone). EDC/PPCP reactivity with oxidants were separated into three general groups: (1) compounds easily oxidized (>80% reacted) by chlorine are always oxidized at least as efficiently by ozone; (2) 6 of the -60 compounds (TCEP, BHC, chlordane, dieldrin, heptachlor epoxide, musk ketone) were poorly oxidized (<20% reacted) by chlorine or ozone; (3) compounds (24 of 60) reacting preferentially (higher removals) with ozone rather than chlorine. Conventional treatment (coagulation plus chlorination) would have low removal of many EDC/PPCPs, while addition of PAC and/or ozone could substantially improve their removals. Existing strategies that predict relative removals of herbicides, pesticides, and other organic pollutants by activated carbon or oxidation can be directly applied for the removal of many EDC/PPCPs, but these strategies need to be modified to account for charged (protonated bases or deprotonated acids) and aliphatic species. Some compounds (e.g., DEET, ibuprofen, gemfibrozil) had low removals unless ozonation was used. Other compounds had low removals by all the WTP processes considered (atrazine, iopromide, meprobamate, TCEP), and removal processes capable of removing these types of compounds should be investigated.
Similar articles
-
Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.Water Res. 2014 Mar 15;51:266-76. doi: 10.1016/j.watres.2013.10.070. Epub 2013 Nov 7. Water Res. 2014. PMID: 24262763
-
Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.Sci Total Environ. 2012 Nov 15;439:18-25. doi: 10.1016/j.scitotenv.2012.08.090. Epub 2012 Oct 9. Sci Total Environ. 2012. PMID: 23059968
-
Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.Water Res. 2009 Oct;43(18):4707-17. doi: 10.1016/j.watres.2009.07.031. Epub 2009 Aug 6. Water Res. 2009. PMID: 19695660
-
Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.J Water Health. 2009 Jun;7(2):224-43. doi: 10.2166/wh.2009.021. J Water Health. 2009. PMID: 19240349 Review.
-
Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.J Hazard Mater. 2007 Nov 19;149(3):631-42. doi: 10.1016/j.jhazmat.2007.07.073. Epub 2007 Jul 28. J Hazard Mater. 2007. PMID: 17826898 Review.
Cited by
-
Electrochemical oxidation of acetaminophen and its transformation products in surface water: effect of pH and current density.Heliyon. 2020 Feb 8;6(2):e03394. doi: 10.1016/j.heliyon.2020.e03394. eCollection 2020 Feb. Heliyon. 2020. PMID: 32072068 Free PMC article.
-
Photodegradation of gemfibrozil in aqueous solution under UV irradiation: kinetics, mechanism, toxicity, and degradation pathways.Environ Sci Pollut Res Int. 2016 Jul;23(14):14294-306. doi: 10.1007/s11356-016-6451-5. Epub 2016 Apr 7. Environ Sci Pollut Res Int. 2016. PMID: 27055889
-
Removal of Non-Steroidal Anti-Inflammatory Drugs from Aqueous Environments with Reusable Ionic-Liquid-based Systems.ACS Sustain Chem Eng. 2017 Mar 6;5(3):2428-2436. doi: 10.1021/acssuschemeng.6b02771. Epub 2017 Jan 11. ACS Sustain Chem Eng. 2017. PMID: 30271684 Free PMC article.
-
Expert stakeholders' views on the management of human pharmaceuticals in the environment.Environ Manage. 2006 Nov;38(5):853-66. doi: 10.1007/s00267-005-0306-z. Epub 2006 Sep 2. Environ Manage. 2006. PMID: 16955232
-
Occurrence of cardiovascular drugs in the sewage-impacted Vistula River and in tap water in the Warsaw region (Poland).Environ Sci Pollut Res Int. 2016 Dec;23(23):24337-24349. doi: 10.1007/s11356-016-7668-z. Epub 2016 Sep 21. Environ Sci Pollut Res Int. 2016. PMID: 27655616
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous